更新的脑损伤指南对复杂轻度创伤性脑损伤的外部验证:一项回顾性队列研究
该回顾性队列研究在加拿大三家一级创伤中心纳入477例复杂轻度创伤性脑损伤(GCS 13-15分)患者,验证更新的脑损伤指南(uBIG)预测院际转运需求的敏感性和特异性。结果显示uBIG-1组无患者接受神经外科干预或死于脑损伤,预测转运需求的敏感性为100%(95%CI 93.2%-100%),特异性为9.4%(95%CI 6.8%-12.6%)。作者认为uBIG-1患者可在初始中心安全治疗而无需转运,但uBIG标准仍需进一步优化以提高特异性。
要点
- uBIG-1组无患者接受神经外科干预或死于脑损伤。
- uBIG预测转运需求的敏感性为100%(95%CI 93.2%-100%),特异性为9.4%(95%CI 6.8%-12.6%)。
- 使用uBIG可能减少6%至25%的转运。
核心结论
- uBIG-1患者可在初始中心安全治疗,无需转运至更高水平神经创伤中心。
- uBIG可减少转运数量,但标准仍需进一步优化以提高特异性。
研究设计与样本
- 回顾性队列研究,在加拿大三家一级创伤中心进行。
- 连续纳入2016年9月至2017年12月期间就诊的年龄≥16岁、GCS评分13-15分的复杂轻度创伤性脑损伤患者。
- 排除穿透性创伤以及有记录脑肿瘤或动脉瘤的患者。
- 主要结局为神经外科干预和/或mTBI相关死亡的复合终点。
- 共纳入477例患者。
主要发现
- 8.4%的患者接受神经外科干预,3%的患者死于mTBI。
- 40例(8%)分类为uBIG-1,168例(35%)为uBIG-2,269例(56%)为uBIG-3。
- uBIG-1组无患者接受神经外科干预或死于损伤。
- 预测转运需求的敏感性为100%(95%CI 93.2%-100%),特异性为9.4%(95%CI 6.8%-12.6%)。
- 使用uBIG可能减少6%至25%的转运。
关键数值与推荐
- uBIG-1组:无神经外科干预或死亡,预测转运需求的敏感性100%(95%CI 93.2%-100%)。
- uBIG预测转运需求的总体特异性9.4%(95%CI 6.8%-12.6%)。
- 使用uBIG可能减少转运6%至25%。
临床怎么用
- 作者认为uBIG-1患者可在初始中心安全治疗,无需转运至更高水平神经创伤中心。
- 作者指出uBIG可减少转运数量,但标准仍需进一步优化以提高特异性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Approximately 10% of patients with mild traumatic brain injury (mTBI) have intracranial bleeding (complicated mTBI) and 3.5% eventually require neurosurgical intervention, which is mostly available at centers with a higher level of trauma care designation and often requires interhospital transfer. In 2018, the Brain Injury Guidelines (BIG) were updated in the United States to guide emergency department care and patient disposition for complicated mild to moderate TBI. The aim of this study was to validate the sensitivity and specificity of the updated BIG (uBIG) for predicting the need for interhospital transfer in Canadian patients with complicated mTBI. METHODS: This study took place at three level I trauma centers. Consecutive medical records of patients with complicated mTBI (Glasgow Coma Scale score 13-15) who were aged ≥ 16 years and presented between September 2016 and December 2017 were retrospectively reviewed. Patients with a penetrating trauma and those who had a documented cerebral tumor or aneurysm were excluded. The primary outcome was a combination of neurosurgical intervention and/or mTBI-related death. Sensitivity and specificity analyses were performed. RESULTS: A total of 477 patients were included, of whom 8.4% received neurosurgical intervention and 3% died as a result of their mTBI. Forty patients (8%) were classified as uBIG-1, 168 (35%) as uBIG-2, and 269 (56%) as uBIG-3. No patients in uBIG-1 underwent neurosurgical intervention or died as a result of their injury. This translates into a sensitivity for predicting the need for a transfer of 100% (95% CI 93.2%-100%) and a specificity of 9.4% (95% CI 6.8%-12.6%). Using the uBIG could potentially reduce the number of transfers by 6% to 25%. CONCLUSIONS: The patients in uBIG-1 could be safely managed at their initial center without the need for transfer to a center with a higher level of neurotrauma care. Although the uBIG could decrease the number of transfers, further refinement of the criteria could improve its specificity.
引用
- Tourigny JN, Boucher V, Paquet V, et al. External validation of the updated Brain Injury Guidelines for complicated mild traumatic brain injuries: a retrospective cohort study. J Neurosurg. 2022. PMID: 35078154. doi:10.3171/2021.10.JNS211794
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。